Dr Linda Allan

Academic Director, Master’s in Bioscience Enterprise, Institute of Biotechnology at Department of Chemical Engineering and Biotechnology, University of Cambridge

Academic Director, Master’s in Bioscience Enterprise, Institute of Biotechnology, University of Cambridge

The Master's in Bioscience Enterprise (MBE) programme is a professional practice course designed for those who have the ambition to found technology companies or take up leadership, executive or consultancy roles in the life science sector. Students are based at the Institute of Biotechnology, part of the Department of Chemical Engineering and Biotechnology, and have a close affiliation to Judge Business School. Learning is based on real business scenarios and lectures and case studies are frequently delivered by senior company executives from the regional and national life science business sector. The course (together with the Institute) has been honoured by the award of the Queen's Anniversary Prize for Further and Higher Education in 2007.

The MBE syllabus comprises a series of interdisciplinary modules covering the commercial exploitation of the latest advances in biotechnology (small molecule and biotherapeutic drug development, medical devices, diagnostics, agbiotech) together with the business and management skills (strategy, decision-making, accounting and finance, financial analysis, company and healthcare economics, pricing, market access, regulatory issues, intellectual property, corporate law) associated with bringing scientific opportunities to market.

Linda joined the MBE programme in 2005, prior to which she founded and was CEO of a company that provided technology-focused executive education and networking events in Cambridge and London. Clients included the Cambridge Enterprise Conference. In her research career Linda studied the physiology of the parasite Trypanosoma brucei and characterised monoclonal and polyclonal antibodies to elucidate the immunological basis of host / parasite interactions during PhD studies and post-doctoral research at The Molteno Institute (the Medical Research Council Biochemical Parasitology Unit) and the Cambridge Department of Biochemistry. Thereafter she lived in Massachusetts for several years, during which time she developed an interest in factors influencing high tech companies and their development.